Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women.

Cerda A, Issa MH, Genvigir FD, Rohde CB, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RD.

J Steroid Biochem Mol Biol. 2013 Nov;138:403-9. doi: 10.1016/j.jsbmb.2013.08.017. Epub 2013 Sep 3.

PMID:
24007717
2.

Relationship of short tandem repeats flanking leptin-melanocortin pathway genes with anthropometric profile and leptinemia in Brazilian individuals.

Hinuy HM, Arazi SS, Hirata MH, Sampaio MF, Armaganijan D, Cavalli SA, Hirata RD.

Arq Bras Endocrinol Metabol. 2012 Feb;56(1):47-53.

PMID:
22460195
3.

Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women.

Issa MH, Cerda A, Genvigir FD, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RD.

J Steroid Biochem Mol Biol. 2012 Feb;128(3-5):139-44. doi: 10.1016/j.jsbmb.2011.11.001. Epub 2011 Nov 7.

4.

Lipoprotein lipase PvuII polymorphism is associated with variations in serum lipid levels in non-diabetic pregnant women.

Sepetiba RJ, Andrade J, Hirata RD, Hirata MH, Sepetiba CR, Nakamura Y, Matsumoto LO, Cavalli SA, Bertolami MC.

Braz J Med Biol Res. 2007 Jul;40(7):919-26.

5.

APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals.

Sorkin SC, Forestiero FJ, Hirata MH, Guzmán EC, Cavalli SA, Bertolami MC, Salazar LA, Hirata RD.

Clin Chem Lab Med. 2005;43(12):1339-45.

PMID:
16309370
6.

A method to detect the G894T polymorphism of the NOS3 gene. Clinical validation in familial hypercholesterolemia.

Hirata RD, Salaza LA, Cavalli SA, Yoshioka KK, Matsumoto LO, Santos ST, Giannini SD, Forti N, Diament J, Doi SQ, Hirata MH.

Clin Chem Lab Med. 2002 May;40(5):436-40.

PMID:
12113283
7.

Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations.

Salazar LA, Hirata MH, Cavalli SA, Nakandakare ER, Forti N, Diament J, Giannini SD, Bertolami MC, Hirata RD.

Hum Mutat. 2002 Apr;19(4):462-3.

PMID:
11933210
8.

Rapid detection of 3500Q and 3531 mutations and MspI polymorphism in exon 26 at the apolipoprotein B gene.

Cavalli SA, Hirata MH, Hirata RD.

J Clin Lab Anal. 2001;15(1):35-9.

PMID:
11170232
9.

Detection of MboII polymorphism at the 5' promoter region of CYP3A4.

Cavalli SA, Hirata MH, Hirata RD.

Clin Chem. 2001 Feb;47(2):348-51. No abstract available.

10.

Apolipoprotein B gene polymorphisms: prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from Brazil.

Cavalli SA, Hirata MH, Salazar LA, Diament J, Forti N, Giannini SD, Nakandakare ER, Bertolami MC, Hirata RD.

Clin Chim Acta. 2000 Dec;302(1-2):189-203.

PMID:
11074075
11.

Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemia.

Salazar LA, Cavalli SA, Hirata MH, Diament J, Forti N, Giannini SD, Nakandakare ER, Bertolami MC, Hirata RD.

Braz J Med Biol Res. 2000 Nov;33(11):1301-4.

12.

Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing.

Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RD.

Clin Chem. 1998 Aug;44(8 Pt 1):1748-50. No abstract available.

Supplemental Content

Loading ...
Support Center